3.62
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| XBiotech Inc | XBIT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 3.62 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.62 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 3.55 - 16.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.62 | USD |
Period:
Draw Mode:
XBiotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 110.19M | 30.44M | 23.59M | $ 18.39M | $ -17.42M | -0.58 | -4.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 100.00k | 22.50% |
XBiotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XBIT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.70 | 3.77 | 3.55 | 3.63 | 37,496 | -0.08 | -2.16% |
| 1 Month | 4.05 | 4.355 | 3.55 | 3.95 | 42,213 | -0.43 | -10.62% |
| 3 Months | 5.72 | 5.72 | 3.55 | 4.61 | 51,612 | -2.10 | -36.71% |
| 6 Months | 9.19 | 9.27 | 3.55 | 5.92 | 97,556 | -5.57 | -60.61% |
| 1 Year | 13.00 | 16.47 | 3.55 | 8.18 | 81,610 | -9.38 | -72.15% |
| 3 Years | 9.20 | 33.20 | 3.55 | 16.16 | 184,716 | -5.58 | -60.65% |
| 5 Years | 4.39 | 33.20 | 2.13 | 13.47 | 154,587 | -0.77 | -17.54% |
XBiotech Description
| XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. |